Mr. Ma joined CMS in 1995 and remained with the Group since then. Mr. Ma has been engaged in sales and marketing management in the Group, possessing over 15 years of sales and marketing management experience. Mr. Ma graduated from Shenzhen University in 1990, majoring in business administration. He obtained the degree of Executive Master of Business Administration (EMBA) from University of Macau in 2022.
Mr. Jiang joined CMS in 1999 after receiving his bachelor’s degree from college and remained with the Group since then. He was promoted to managerial positions rapidly after training at junior positions, having made outstanding sales contribution during the period. Mr. Jiang is currently responsible for the overall operations and management of Shenzhen Kangzhe, possessing over 20 years of sales and marketing experience and rich experience in operations and management. Mr. Jiang obtained a bachelor’s degree in clinical medicine from Anhui Medical University in 1999.
Ms. Li joined CMS in 2003 and remained with the Group since then. Ms. Li was the Director of the Compliance Department of the Group. Ms. Li possesses over 10 years of finance, tax and pharmaceutical companies’compliance experience. Ms. Li obtained a bachelor’s degree of management in electronic data processing accounting from Jilin University of Finance and Economics in 2001. She is a non-practicing member of Shenzhen Institute of Certified Public Accountants.
Mr. Fan, joined CMS in August 2024. Mr. Fan has over 25 years of management experience in pharmaceutical companies, including drug market promotion, channel management, supply chain management, bidding standards entry, and digital marketing. Prior to joining the Group, Mr. Fan worked in several pharmaceutical companies, serving as national sales director, head of channel and business department, head of off-hospital markets and Co-Chief Executive Officer, etc. Mr. Fan obtained a bachelor’s degree in business administration and an EMBA degree from South China University of Technology in January 2012 and June 2014, respectively. He graduated from Qinghai Minzu University with a major in Politics and History in 1992.
Mr. Cai, joined CMS in August 2024. Mr. Cai has 20 years of sales and market management experience in the pharmaceutical field, as well as 7 years of experience in commercialization management of tumour, infection IVD, and LDT. Mr. Cai has rich experience in building commercial teams and consistently achieving performance targets. He is skilled in team management and breakthroughs in new business ventures, with expertise in systematic business planning and implementation. Prior to joining the Group, Mr. Cai worked in a number of pharmaceutical companies, serving as sales director, marketing director, director of Strategic Marketing Department, Senior Vice President and Chief Commercial Officer, etc. Mr. Cai worked as a resident physician at Qingdao the People’s Liberation Army 141 Hospital from 1994 to 1996 and had approximately 2 years of experience as a physician in a public hospital. Mr. Cai obtained a bachelor’s degree in clinical medicine from the First […]
Mr. Huang joined CMS in 2005 after receiving his master’s degree from college and remained with the Group since then. Mr. Huang is currently responsible for the overall operations and management of CMS Skinhealth, possessing over 10 years of sales and marketing experience and rich experience in operations and management. Prior to joining the Group, Mr. Huang had acquired about 3 years’ experience as a doctor at a public hospital. Mr. Huang obtained a master’s degree in pediatrics in traditional Chinese medicine from Shandong University of Traditional Chinese Medicine in 2005.
Dr. Peng was appointed as an independent non-executive Director of the Company for the period from 4 May 2010 to 9 October 2013 and has remained with the Group since then. Prior to joining the Group, he held the positions of partner, director or senior portfolio manager at several multinational financial corporations in the UK and Canada, mainly engaged in investments in the global life science field. Dr. Peng possesses over 17 years of investment experience. Dr. Peng obtained a bachelor’s degree and a master’s degree in clinical medicine from Hunan Medical College in 1984 and 1989 respectively, and his doctoral degree of philosophy in molecular pathology from University College London Medical School, UK in 1998. Prior to entering into the financial investment and pharmaceutical industries, Dr. Peng was a clinical instructor of histopathology at the University College London Medical School.
Mr. Jiang joined CMS in January 2022. Prior to joining the Group, Mr. Jiang was engaged in R&D and business expansion in domestic pharmaceutical companies, and held the positions including executive director and managing director at several venture capital firms and private equity funds. He possesses over 10 years of work experience in China’s pharmaceutical industry and approximately 6 years of investment experience. Mr. Jiang obtained a bachelor’s degree in chemical engineering from East China University of Science and Technology in 1998 and his doctoral degree of philosophy in chemical engineering from Syracuse University, U.S. in 2006.
Mr. Stearns joined CMS in April 2021. Prior to joining the Group, he was a director of a well-known investment bank and the investment director of an independent private equity firm, possessing over 10 years of experience in investment and finance in Europe and America’s pharmaceutical industries. Mr. Stearns obtained a bachelor’s degree in economics and accounting from University of Bristol in 2000.
Ms. Wang joined CMS in 2004 after receiving her master’s degree from college and remained with the Group since then. Ms. Wang is currently responsible for the overall operations and management of CMS Vision, possessing over 10 years of sales and marketing experience and rich experience in operations and management. Ms. Wang obtained a bachelor’s degree in preventive medicine and a master’s degree in epidemiology and health statistics from West China Medical Center, Sichuan University in 2001 and 2004 respectively.
Ms. Wu joined CMS in 2009 and remained with the Group since then. Ms. Wu is primarily responsible for overseeing the legal and regulatory compliance matters of the Group (including compliance with the Listing Rules), possessing over 10 years of legal and corporate governance experience. Ms. Wu obtained a double bachelor’s degree in history and law in 2004, and a master’s degree in international law in 2008, both from Wuhan University.
